Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TELA Bio (TELA)
NASDAQ:TELA
Holding TELA?
Track your performance easily
TELA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.40 - $8.30
Previous Close$2.59
Volume42.03K
Average Volume (3M)277.58K
Market Cap
$64.01M
Enterprise Value$78.33M
Total Cash (Recent Filing)$26.50M
Total Debt (Recent Filing)$40.82M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Nov 06, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.72
Shares Outstanding24,713,798
10 Day Avg. Volume281,418
30 Day Avg. Volume277,578
Standard Deviation0.16
R-Squared0.11
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)21.58
Price to Sales (P/S)0.99
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.21
Enterprise Value/Gross Profit1.95
Enterprise Value/Ebitda-2.21
Forecast
1Y Price Target
$10.00Price Target Upside286.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
TELA Bio News
PremiumCompany Announcements
TELA Bio Reports Q3 2024 Preliminary Financial Results
Bulls Say, Bears Say
Bulls Say
Business MomentumCombining a robust product portfolio with an increasingly seasoned salesforce, expanding GPO implementation, and robotic adoption tailwinds, TELA is nearing an inflection point in its business.
Market PositionTELA is disrupting a multibillion market and has the best positioned product portfolio to capitalize on the multi-$100M shift away from synthetics.
Product PortfolioTELA has the sales force, product portfolio, GPO access, and clinical validation to establish OviTex as a standard of care.
Bears Say
EarningsQ2 revenue of $16.1M (+11% Y/Y) was below the Street’s expectation of $18.4M.
Litigation RisksMounting litigation could deter surgeons from using permanent plastic mesh further, providing yet another reason to choose TELA's products.
Operational ChallengesTELA missed top- and bottom-line expectations in the Q2, growing 11% Y/Y as it hit unexpected roadblocks with two cybersecurity attacks, lightness in procedural volumes, and death or departure of three of its surgeon users.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TELA FAQ
What was TELA Bio’s price range in the past 12 months?
TELA Bio lowest stock price was $2.40 and its highest was $8.30 in the past 12 months.
What is TELA Bio’s market cap?
Currently, no data Available
When is TELA Bio’s upcoming earnings report date?
TELA Bio’s upcoming earnings report date is Nov 06, 2024 which is in 6 days.
How were TELA Bio’s earnings last quarter?
TELA Bio released its earnings results on Aug 12, 2024. The company reported -$0.51 earnings per share for the quarter, missing the consensus estimate of -$0.457 by -$0.053.
Is TELA Bio overvalued?
According to Wall Street analysts TELA Bio’s price is currently Undervalued.
Does TELA Bio pay dividends?
TELA Bio does not currently pay dividends.
What is TELA Bio’s EPS estimate?
TELA Bio’s EPS estimate is -$0.41.
How many shares outstanding does TELA Bio have?
TELA Bio has 24,713,799 shares outstanding.
What happened to TELA Bio’s price movement after its last earnings report?
TELA Bio reported an EPS of -$0.51 in its last earnings report, missing expectations of -$0.457. Following the earnings report the stock price went down -22.943%.
Which hedge fund is a major shareholder of TELA Bio?
Currently, no hedge funds are holding shares in TELA
---
TELA Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (286.10% Upside)
$10.00 (286.10% Upside)
Blogger Sentiment
Bullish
TELA Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.02%
12-Months-Change
Fundamentals
Return on Equity
-196.42%
Trailing 12-Months
Asset Growth
-36.22%
Trailing 12-Months
Company Description
TELA Bio
TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
---
TELA Earnings Call
Q2 2024
0:00 / 0:00
---
TELA Stock 12 Month Forecast
Average Price Target
$10.00
▲(286.10% Upside)
Technical Analysis
Best Analysts Covering TELA
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-19.19%
reiterated a buy rating 3 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -19.19% per trade.
---